SCHEMBL17482007

SCHEMBL17482007

Cc1ccc2c(c1)c1cc(Cl)ccc1n2CCC(=O)NO

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 5/20 0.54
HDAC2 Q92769 1/20 0.53
MAPT P10636 2/20 0.53
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
LMNA P02545 1/20 0.53
ALOX12 P18054 1/20 0.53
MAPK1 P28482 1/20 0.53
TP53 P04637 4/20 0.50
KDM4E B2RXH2 2/20 0.46
POLB P06746 1/20 0.46
HSD17B10 Q99714 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
BAZ2B Q9UIF8 1/20 0.45
HDAC1 Q13547 3/20 0.44
ALOX15 P16050 1/20 0.43
CYP2C9 P11712 1/20 0.43
PTGDR2 Q9Y5Y4 1/20 0.43
RXFP1 Q9HBX9 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17474413 0.92 HDAC6 (0.62) HDAC6HDAC2MAPTMEN1KMT2A
SCHEMBL17482003 0.88 MAPT (0.52) HDAC2MAPTMEN1KMT2ALMNA
SCHEMBL16156844 0.85 KDM4E (0.63) MAPTMEN1KMT2ALMNAALOX12
SCHEMBL17482044 0.80 TP53 (0.53) MAPTTP53KDM4EPOLBHSD17B10
SCHEMBL17484538 0.79 KDM4E (0.51) HDAC6HDAC2MAPTMEN1KMT2A
SCHEMBL15286669 0.79 KMT2A (0.55) HDAC6MAPTMEN1KMT2ALMNA
SCHEMBL16558097 0.77 MEN1 (0.55) MAPTMEN1KMT2ALMNAALOX12
SCHEMBL15286161 0.76 MAPT (0.52) MAPTMEN1KMT2ALMNAALOX12
SCHEMBL15286444 0.75 FABP4 (0.59) MAPTMEN1KMT2ALMNAALOX12
SCHEMBL16156848 0.75 KDM4E (0.73) HDAC2MAPTKDM4EPOLBHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9862684-B2 Modulation of K2P channels THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2018-01-09 US disclosed
US-20160031814-A1 MODULATION OF K2P CHANNELS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2016-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160031814-A1 MODULATION OF K2P CHANNELS KCNJ2, KCNK2, KCNN3 HDAC6 447/4885HDAC2 249/4885MAPT 226/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.